Рет қаралды 4,171
Solve M.E. hosted a webinar with the Hope Biosciences Research Foundation (HBRF), which has conducted three FDA-authorized studies in mesenchymal cell therapy for COVID-19 prevention and treatment, and two studies in Long Covid.
Hear Solve President Oved Amitay and HBRF founder Donna Chang deliver a comprehensive discussion of findings and more information about a Long Covid study that is currently enrolling, as well as the potential for future studies in ME/CFS.